Saturday Program

Simultaneous Sessions | Clinical Trial Update | Science in progress | Hematology-in-focus Session | Lunch Debates | Meet-the-Expert | 5th EHA / ASH Joint Symposium | EHA Business Meeting | Jean Bernard Lifetime Achievement Award | Presidential Symposium | Plenary Session 1 | Poster Session II

PRESIDENTIAL SYMPOSIUM

15:00 – 16:30, Hall A1

PRESIDENTIAL SYMPOSIUM: 5 BEST ABSTRACTS

Chairs: W Fibbe (University Medical Center, Leiden, The Netherlands)
N Borregaard (Rigshospitalet, Copenahgen, Denmark)

15:00 – 15:17
0471 MUTATION IN TMPRSS6, A SUPPRESSOR OF HEPCIDIN GENE EXPRESSION, IN FAMILIAL IRON DEFICIENCY ANEMIA
M.A. Melis, M. Cau, R. Congiu, S. Barella, A. Cao, M. Westerman,
M. Cazzola, R. Galanello (University of Cagliari, Cagliari, Italy)

15:17 – 15:34
0472 BIALLELIC MUTATIONS IN THE TELOMERASE COMPONENT NHP 2 CAUSE THE PREMATURE AGEING SYNDROME DYSKERATOSIS CONGEINTA
T. Vulliamy, R. Beswick, M. Kirwan, A. Marrone, M. Digweed, A. Walne,
I. Dokal (Barts and The London School of Medicine and Dentistry,
London, United Kingdom)

15:34 – 15:51
0473 SUPERIOR EFFICACY WITH BORTEZOMIB PLUS MELPHALAN–PREDNISONE (VMP) VERSUS MELPHALAN–PREDNISONE (MP) ALONE IN PREVIOUSLY UNTREATED MULTIPLE MYELOMA (MM): RESULTS OF THE PHASE III MMY-3002 VISTA STUDY
J. San-Miguel, R. Schlag, N. Khuageva, M. Dimopoulos, O. Shpilberg,
M. Kropff, I. Spicka, M. Petrucci, A. Palumbo, O. Samoilova,
A. Dmoszynska, K. Abdulkadyrov, R. Schots, B. Jiang, M. Mateos,
K. Anderson, D. Esseltine, K. Liu, A. Cakana, H. Van de Velde,
P. Richardson (Hospital Universitario de Salamanca, Salamanca, Spain)

15:51 – 16:08
0474 UNIQUE ACTIVATING MUTATIONS OF JAK2 IN THE ACUTE LYMPHOBLASTIC LEUKEMIAS OF DOWN SYNDROME -BIOLOGICAL AND THERAPEUTIC APPLICATIONS
S. Izraeli, I. Ganmore, D. Bercovich, L.M. Scott, G. Wainreb, A. Elimelech,
G. Cazzaniga, A. Biondi, G. Basso, G. Cario, M. Schrappe, M. Stanulla,
S. Strehl, O.A. Haas, G. Mann, V. Binder, A. Borkhardt, H. Kempski,
J. Trka, S. Avigad, B. Stark, B. Bielorei, O. Smith, N. Dastugue,
J.P. Bourquin, A.R. Green (Sheba medical center, Ramat Gan, Israel)

16:08 – 16:25
0475 IFN-A PROMOTES PROLIFERATION OF DORMANT HSCS N VIVO, MAKING THEM SUSCEPTIBLE TO ELIMINATION BY CHEMOTHERAPY
M.A.G. Essers, S. Offner, W.E. Blanco-Bose, Z. Waibler, U. Kalinke,
M. Duchosal, A. Trumpp (ISREC, School of life sciences, EPFL,
Epalinges, Switzerland)